Nasonex

Medicinal product

(Invented) name

Nasonex

Active substance (s)

Mometazono furoatas

Strength

50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-04-03

Date of renewal

Documents

2463_Nasonex_pursk_140_N1_N3_PIL.docx

2463_Nasonex_pursk_140_N1_N3_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje yra:	1 dozėje
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117184	103284	1103284	buteliukas	140 dozių N1		Receptinis	LT/L/25/2463/001	Tiekiama	2025-07-17	-	No	-	-	Download
117185	103285	1103285	buteliukas	140 dozių N3		Receptinis	LT/L/25/2463/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-04-03	Registruotas